Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified 2020-06-02 16:00
icometrix launches its icompanion platform for people with multiple sclerosis 2020-06-02 15:00
Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology 2020-06-02 13:28
Adagio Medical Receives CE Mark Approval for its iCLAS(TM) Cryoablation System and Prepares for European Commercial Launch 2020-06-02 11:25
icometrix launches its icompanion platform for people with multiple sclerosis 2020-06-02 08:00
Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study 2020-06-02 07:30
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings 2020-06-02 06:00
China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering 2020-06-01 21:25
Cynosure Launches Elite iQ™ Aesthetic Workstation For Laser Hair Removal and Skin Revitalization in the United States, Europe and Australia 2020-06-01 20:45
Alchera exports a preventive solution of COVID-19 to San Pedro Square Market, San Jose 2020-06-01 20:30
Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR® 2020-06-01 15:22
Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab) 2020-06-01 13:48
UOB intensifies COVID-19 safety measures by applying self-disinfecting coating at high-touch areas within its branches island-wide 2020-06-01 11:53
Uniview Temperature Screening Solutions Help Thailand Government to Fight Against COVID 19 2020-06-01 11:34
NCH Asia Pacific announces the specialized 'NCH Disinfection Program' to keep NCH customers' business running and protecting their customers 2020-06-01 09:00
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal 2020-06-01 08:45
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma 2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type) 2020-06-01 07:30
1 768 769 770 771 772 1597